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IMPORTANCE Lower back pain (LBP) is a prevalent and challenging condition in primary care.
The effectiveness of an individually tailored self-management support tool delivered via
a smartphone app has not been rigorously tested.
OBJECTIVE To investigate the effectiveness of SELFBACK, an evidence-based, individually
tailored self-management support system delivered through an app as an adjunct to usual
care for adults with LBP-related disability.
DESIGN, SETTING, AND PARTICIPANTS This randomized clinical trial with an intention-to-treat
data analysis enrolled eligible individuals who sought care for LBP in a primary care or an
outpatient spine clinic in Denmark and Norway from March 8 to December 14, 2019.
Participants were 18 years or older, had nonspecific LBP, scored 6 points or higher on the
Roland-Morris Disability Questionnaire (RMDQ), and had a smartphone and access to email.
INTERVENTIONS The SELFBACK app provided weekly recommendations for physical activity,
strength and flexibility exercises, and daily educational messages. Self-management
recommendations were tailored to participant characteristics and symptoms. Usual care
included advice or treatment offered to participants by their clinician.
MAIN OUTCOMES AND MEASURES Primary outcome was the mean difference in RMDQ scores
between the intervention group and control group at 3 months. Secondary outcomes
included average and worst LBP intensity levels in the preceding week as measured on the
numerical rating scale, ability to cope as assessed with the Pain Self-Efficacy Questionnaire,
fear-avoidance belief as assessed by the Fear-Avoidance Beliefs Questionnaire, cognitive and
emotional representations of illness as assessed by the Brief Illness Perception Questionnaire,
health-related quality of life as assessed by the EuroQol-5 Dimension questionnaire, physical
activity level as assessed by the Saltin-Grimby Physical Activity Level Scale, and overall
improvement as assessed by the Global Perceived Effect scale. Outcomes were measured
at baseline, 6 weeks, 3 months, 6 months, and 9 months.
RESULTS A total of 461 participants were included in the analysis; the population had
a mean [SD] age of 47.5 [14.7] years and included 255 women (55%). Of these participants,
232 were randomized to the intervention group and 229 to the control group. By the
3-month follow-up, 399 participants (87%) had completed the trial. The adjusted mean
difference in RMDQ score between the 2 groups at 3 months was 0.79 (95% CI, 0.06-1.51;
P = .03), favoring the SELFBACK intervention. The percentage of participants who reported
a score improvement of at least 4 points on the RMDQ was 52% in the intervention group
vs 39% in the control group (adjusted odds ratio, 1.76; 95% CI, 1.15-2.70; P = .01).
CONCLUSIONS AND RELEVANCE Among adults who sought care for LBP in a primary care or
an outpatient spine clinic, those who used the SELFBACK system as an adjunct to usual care
had reduced pain-related disability at 3 months. The improvement in pain-related disability
was small and of uncertain clinical significance. Process evaluation may provide insights into
refining the SELFBACK app to increase its effectiveness.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT03798288
JAMA Intern Med. doi:10.1001/jamainternmed.2021.4097
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L ower back pain (LBP) is the leading cause of disabilityworldwide, and its burden is expected to grow in thecoming decades.1-3 In the United States, LBP accounts
for at least 264 million lost workdays per year, equating to more
than 2 lost workdays per year for every full-time employee.4
Despite the vast amount of allocated health care resources,
the burden of LBP has increased substantially over the past 3
decades.5 In 2016, lower back and neck pain accounted for the
highest amount of health care spending in the United States.6
In the United States, LBP is the third most common rea-
son for individuals to visit their primary care physician.7 A
specific cause of LBP can rarely be identified and is most often
diagnosed as being nonspecific.8 Evidence-based self-
management support that is tailored to the needs and abilities
of the patient is recommended as part of the first-line treat-
ment for nonspecific LBP.9-12 This support includes providing
patients with adequate information, reassurance, and educa-
tion as well as advice to maintain daily activities and exercise
regularly.11,13 However, primary care physicians generally lack
the time, resources, and training to deliver such support,14 and
adherence to self-management recommendations without
feedback or reinforcement is challenging for most patients.15
Smartphone technology along with knowledge-driven artifi-
cial intelligence (AI) can be used to make tailored self-
management support available to patients.16 A recent meta-
analysis of randomized clinical trials concluded that e-health
programs may be beneficial in LBP self-management.17
Informed by current best clinical evidence and knowledge-
driven AI, we developed SELFBACK, an innovative decision
support system, to facilitate, improve, and reinforce self-
management of LBP.18 In this randomized clinical trial, we in-
vestigated the effectiveness of SELFBACK, an evidence-
based, individually tailored self-management support system
delivered via an app as an adjunct to usual care for adults with
LBP-related disability who sought care in a primary care or an
outpatient spine clinic. We hypothesized that patients who
were randomized to receive the SELFBACK intervention would
have a lower LBP-related disability score and favorable other
outcomes after 3 months compared with those who were ran-
domized to receive usual care alone.
Methods
Study Design, Setting, and Participants
The randomized clinical trial was approved by the Danish Data
Protection Agency and regional ethics committees in Den-
mark and Norway. All potential participants provided written
informed consent before trial enrollment. The trial protocol has
been published elsewhere.19,20 We followed the Consoli-
dated Standards of Reporting Trials (CONSORT) reporting
guideline.
We recruited adults who were 18 years or older, had non-
specific LBP within the preceding 8 weeks, scored 6 points or
higher on the Roland-Morris Disability Questionnaire (RMDQ)
at the time of screening, had consulted a clinician (general prac-
titioner, physiotherapist, or chiropractor) in the region of
Southern Denmark or in the Trondheim municipality in
Norway or had undergone a clinical examination at an out-
patient spine clinic (Spine Centre of Southern Denmark), had
a smartphone (with an iOS or Android operating system),
and had access to email. Exclusion criteria were the inability
to carry out the intervention (ie, problems with speaking,
reading, or understanding Danish or Norwegian; mental or
physical conditions that limited participation; or inability to
perform physical exercise), fibromyalgia, previous spinal
surgery, current pregnancy, current participation in other
LBP-focused research, or an RMDQ score lower than 6 points
at screening.
Eligible individuals were enrolled between March 8 to
December 14, 2019. Figure 1 shows the flow of participants
through the trial.
Randomization to Intervention Group or Control Group
Participants completed a web-based questionnaire and were
thereafter randomized. A web-based trial management sys-
tem, administered by the Unit for Applied Clinical Research,
Faculty of Medicine and Health Sciences of the Norwegian
University of Science and Technology, was used in random-
ization. Group allocation was concealed by the trial manage-
ment system until the randomization was performed. Partici-
pants were randomized in a 1:1 ratio using permuted blocks
with random sizes from 4 to 20 and stratified by country
(Denmark or Norway) and clinician (general practitioner, phys-
iotherapist, chiropractor, or outpatient clinic). Participants were
not blinded to group allocation after randomization. Partici-
pants who were randomized to receive usual care (control
group) were instructed to manage their LBP according to the
advice or treatment offered by their clinician. Participants who
were randomized to receive the SELFBACK self-management
support system in addition to usual care (intervention group)
were instructed to install the AI-based SELFBACK app to their
smartphone and to wear a step-detecting wristband (Mi Band
3; Xiaomi) that was connected to the app. The app also works
with other commercially available step-detecting wristbands
and the built-in step counter in smartphones. A research
assistant (including some of us: L.F.S., C.K.Ø., T.D., J.S.D.J., A.K.,
A.L.N., and E.M.B.) guided the app installation and briefly
introduced the app functions in a face-to-face meeting with
the participant. Participants were instructed to use the app
Key Points
Question Is SELFBACK, an evidence-based, individually tailored
self-management support system that is delivered through an
artificial intelligence–based app and in conjunction with usual care,
effective for pain-related disability in adults with lower back pain?
Findings In this randomized clinical trial involving 461 participants
in Denmark and Norway, those who received the SELFBACK
intervention had reduced pain-related disability compared with
those who received usual care alone. However, the effect may be
too small to be clinically meaningful.
Meaning The findings of this trial and process evaluation may
inform and encourage further development of the SELFBACK
intervention to increase its effectiveness.
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at their convenience and for as long as they needed, and no
directives were given regarding the end point of use. They were
informed that the app was a supplement to their usual care and
that they should follow any advice given by their clinician.
The SELFBACK intervention is an evidence-based deci-
sion support system that provides weekly, individually tai-
lored self-management recommendations for 3 main compo-
nents that are endorsed by clinical guidelines11,12,21: (1) physical
activity (number of steps), (2) strength and flexibility exer-
cises, and (3) daily educational messages. In addition, the app
provides general information about LBP and access to several
tools (goal setting, mindfulness audios, pain-relieving exer-
cises, and sleep reminders) that participants could use at their
convenience.
A detailed description of the intervention is presented in
the eAppendix in Supplement 1. The development of the evi-
dence-based content as well as the design, architecture, and
functions of the SELFBACK system have been described in
detail elsewhere.18,22 Briefly, the weekly self-management rec-
ommendations are tailored to the participant’s characteris-
tics, symptoms, and symptom progression, which are re-
ported through the app by using case-based reasoning,23 a
branch of knowledge-driven AI.24,25 In the SELFBACK system,
the core of case-based reasoning is knowledge of previous suc-
cessful cases along with data about the current case, which
enables the system to provide patient-centered recommen-
dations based on current needs and past interventions that
proved effective. By following the weekly recommendations,
participants could collect badges and rewards that are dis-
played on the app. In this trial, encouraging and commend-
ing push notifications, triggered by the participants’ behav-
iors, were sent to the participants’ smartphones to motivate
and reinforce the desired behavior.
Outcomes and Follow-up
Outcomes were evaluated using a web-based questionnaire at
baseline, 6 weeks, 3 months, 6 months, and 9 months. Socio-
demographic information was collected at baseline (Table 1).
Figure 1. CONSORT Diagram
1065 Individuals expressed interest in the study
857 Assessed for eligibility
229 Included in intention-to-treat
analysis at 3-mo follow-up
232 Included in intention-to-treat
analysis at 3-mo follow-up
63 Could not be reached
145 Refused to participate
172 Underwent 6-wk follow-up
190 Underwent 3-mo follow-up
182 Underwent 6-mo follow-up
182 Underwent 9-mo follow-up
11 Discontinued intervention at 6 wk
5 Discontinued intervention at 3 mo
2 Discontinued intervention at 6 mo
2 Discontinued intervention at 9 moc
196 Underwent 6-wk follow-up
209 Underwent 3-mo follow-up
167 Underwent 6-mo follow-up
170 Underwent 9-mo follow-up
4 Discontinued intervention at 6 wk
5 Discontinued intervention at 3 mo
14 Discontinued intervention at 6 mo
3 Discontinued intervention at 9 mod
461 Randomized
396 Excluded
305 Did not meet inclusion criteriaa
27 Refused to participate
64 Other reasonsb
229 Randomized to control group
228 Received usual care
1 Did not receive usual care
(did not want to participate)
232 Randomized to intervention group
232 Received SELFBACK app
a Individuals were excluded for having no lower back pain (n = 48),
a Roland-Morris Disability Questionnaire score lower than 6 points (n = 235),
and inadequate smartphone (n = 22).
b Other reasons for exclusion were being younger than 18 years (n = 2); being
unable to speak, read, or understand the national language (n = 2); having
mental or physical conditions that limited participation (n = 12); being unable
to take part in exercise or physical activity (n = 5); having fibromyalgia
diagnosis (n = 11); participating currently in other lower back research (n = 2);
and having previous back surgery (n = 30).
c Reasons for discontinuation of usual care included work pressure (n = 2),
randomization to usual care (n = 2), unknown reasons (n = 10), personal
reasons (n = 1), lack of time (n = 2), questionnaire issues (n = 1), not
understanding the concept (n = 1), and “too much hassle” (n = 1).
d Reasons for discontinuation of the SELFBACK intervention included work
pressure (n = 2), knee injury (n = 1), unknown reasons (n = 12), surgery (n = 2),
personal reasons (n = 1), lack of time (n = 1), questionnaire issues (n = 2),
technical issues with app or wristband (n = 4), and starting other new
treatment (n = 1).
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Following the prespecified statistical analysis plan (Supple-
ment 2), we assessed the primary outcome as the mean dif-
ference in RMDQ scores between the intervention group and
control group at 3 months. The RMDQ is a reliable and valid
measure of pain-related disability in people with nonspecific
LBP.26 The RMDQ scale ranges from 0 to 24 points, with higher
scores indicating more pain-related disability. In addition, we
examined the difference in the percentage of participants who
reported achieving at least a 2- or 4-point improvement in
RMDQ score. There is no clear consensus on what constitutes
a clinically meaningful change on the RMDQ scale, but sev-
eral studies have indicated that meaningful change is likely to
be a score ranging from 2 to 4 points.27-30
Prespecified secondary outcomes included average and
worst LBP intensity levels in the preceding week as measured
on the numerical rating scale (range: 0-10, with higher scores
indicating higher intensity)31; confidence in ability to cope de-
spite pain as assessed with the Pain Self-Efficacy Question-
naire (range: 0-60, with higher scores indicating greater
confidence)32; fear-avoidance belief as assessed by the Fear-













Age, mean (SD) [range], y 47.5 (14.7) [18-86] 46.7 (14.4) [18-81] 48.3 (15.0) [20-86]
BMI, mean (SD) [range] 27.6 (5.1) [17-54] 27.8 (5.4) [18-54] 27.3 (4.7) [17-46]
Female sex 255 (55) 134 (59) 121 (52)
Male sex 206 (45) 95 (41) 111 (48)
Educational achievement: >12 y 297 (64) 145 (63) 152 (66)
Full-time employment 281 (61) 143 (62) 138 (59)
Married or living with partner 332 (72) 158 (69) 174 (75)
Clinical setting of patient recruitment
General practitioner 68 (15) 34 (15) 34 (15)
Physiotherapist 135 (29) 67 (29) 68 (29)
Chiropractor 160 (35) 79 (35) 81 (35)
Outpatient back clinic 98 (21) 49 (21) 49 (21)
LBP history
Duration of current pain episode: >12 wk 267 (58) 136 (59) 131 (56)
No. of days with LBP in past year
1-7 17 (4) 6 (3) 11 (5)
8-30 61 (13) 33 (14) 28 (12)
>30 186 (40) 90 (39) 96 (41)
Daily 197 (43) 100 (44) 97 (42)
Use of pain medication
None 94 (20) 50 (22) 44 (19)
1-2 d 85 (18) 39 (17) 46 (20)
3-5 d 125 (27) 66 (29) 59 (25)
Daily 157 (34) 74 (32) 83 (36)
Baseline measure of primary outcome
RMDQ score, range: 0-24, mean (SD) 10.4 (4.4) 10.6 (4.4) 10.3 (4.4)
Baseline measures of secondary outcomes
LBP intensity level, NRS range: 0-10,
mean (SD)
Average pain intensity level in past week 4.9 (1.9) 4.9 (1.9) 4.8 (2.0)
Worst pain intensity level in past week 6.6 (1.9) 6.6 (2.0) 6.6 (1.9)
PSEQ score, range: 0-60, mean (SD) 44.1 (11.1) 43.6 (11.2) 44.6 (10.9)
FABQ score, range: 0-24, mean (SD) 10.3 (5.4) 10.2 (5.2) 10.5 (5.7)
BIPQ score, range: 0-80, mean (SD) 44.0 (10.9) 45.3 (10.4) 42.8 (11.2)
EQ-VAS score, range: 0-100, mean (SD) 66.2 (16.5) 65.2 (16.7) 67.1 (16.3)
EQ-5D weighted score,
range: −0.62 to 1.00, mean (SD)
0.70 (0.13) 0.70 (0.14) 0.71 (0.11)
SGPALS
Sedentary 33 (7) 18 (8) 15 (6)
Some physical activity 239 (52) 121 (53) 118 (51)
Global Perceived Effect scale score,
range: −5 to 5
NA NA NA
Abbreviations: BIPQ, Brief Illness
Perception Questionnaire; BMI, body
mass index (calculated as weight in
kilograms divided by height in meters
squared); EQ-5D, EuroQol-5
Dimension; EQ-VAS, EuroQol visual
analog scale; FABQ, Fear-Avoidance
Beliefs Questionnaire; LBP, lower
back pain; NA, not applicable;
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Avoidance Beliefs Questionnaire physical activity subscale
(range: 0-24, with higher scores indicating greater fear)33; cog-
nitive and emotional representations of illness as assessed by
the Brief Illness Perception Questionnaire (range: 0-80, with
higher scores indicating greater illness perception)34; health-
related quality of life as assessed by the EuroQol-5 Dimen-
sion questionnaire, weighted according to the Danish value set
(range: −0.62 to 1.00, with higher scores indicating better health
status),35 and the EuroQol visual analog scale (range: 0-100,
with higher scores indicating better health status)36; leisure
time physical activity level as assessed by the Saltin-Grimby
Physical Activity Level Scale (4 categories: sedentary, some
physical activity, regular physical activity, and regular hard
physical activity)37; and overall improvement as assessed by
the Global Perceived Effect scale (range: −5 to 5, with scores
above 0 points indicating improvement [anchor: “very much
better”] and scores below 0 points indicating worsening
[anchor: “very much worse”]).38 In line with the prespecified
statistical analysis plan, we examined a set of additional sec-
ondary and exploratory outcomes.
Adverse Events and Power
Participant-reported occurrences of harms and adverse events
were registered and discussed in weekly trial management
meetings.
The planned sample size of at least 350 participants (175
in each group) was based on a power of 90% to detect a 2-point
mean group difference in RMDQ score at 3 months, assuming
an SD of 6 points, a correlation of 0.4 between repeated mea-
sures in the same participants, a 2-sided α = .05, and a 30%
dropout rate during follow-up.19
Statistical Analysis
The primary intention-to-treat analysis estimated the mean
group difference in RMDQ score using a constrained longitu-
dinal data analysis,39,40 in which both the baseline and all
follow-up values were modeled as dependent variables. The
baseline means were constrained to be equal for both groups,
which was reasonable because of the randomization, and the
analyses were thus adjusted for any baseline difference in the
outcome variable. The model included a random intercept
for each participant to account for the dependency in obser-
vations within participants over time. Results were presented
as mean differences with 95% CIs between the intervention
group and control group at 3- and 9-month follow-up. Fol-
lowing evidence-based recommendations,41,42 we adjusted
all effect estimates for variables used to stratify the random-
ization (by country and clinician) and for potentially impor-
tant predictors of the outcome (age [years], sex [male vs
female], educational achievement [<10, 10-12, or >12 years],
duration of current pain episode [<1, 1-4, 5-12, or >12 weeks],
and average pain intensity level in the past week at baseline
[0-10 scale]).
Preplanned sensitivity analyses of the primary outcome
included (1) multiple imputations of missing values using
a multivariate normal approach and 20 imputed data sets;
(2) a complete case analysis, including participants with data
at all time points; and (3) a per protocol analysis, including
adherent participants in the intervention group (adherence was
defined as creating ≥6 self-management plans during the first
12 weeks after randomization). We assessed the assumptions
related to the normality and homogeneity of residuals as well
as the normality of random intercepts for all models. Analy-
sis of mean group differences in secondary outcomes fol-
lowed the same analytic approach.
We used a generalized estimated equation logistic model
to estimate the odds ratio (OR) for achieving at least a 2- or
4-point improvement in RMDQ score from baseline to each fol-
low-up time point. Similar analyses were performed to esti-
mate the ORs for secondary binary outcomes that were clas-
sified according to clinically meaningful cutoffs. The number
needed to treat was calculated as the inverted risk difference
from a generalized estimated equation Poisson model. For
all generalized estimated equation models, an exchangeable
correlation structure was assumed and a robust variance es-
timator was used.
All estimates of precision were based on 2-sided tests. Sta-
tistical significance was defined as a 2-sided P < .05. All analy-
ses were performed using Stata, version 16.1 (StataCorp LLC).
Results
Among the 1065 individuals who expressed interest in the
study, 461 were randomized to the intervention group (n = 232)
or the control group (n = 229) (Figure 1). Overall, 317 partici-
pants (69%) were recruited in Denmark and 144 participants
(31%) were recruited in Norway. The primary reason for ex-
clusion was an RMDQ score lower than 6 points (n = 235).
Among participants in the intervention group, 181 (78%) ad-
hered to SELFBACK in addition to the usual care intervention.
Complete data on the RMDQ were obtained from 368 partici-
pants (80%) at 6 weeks, 399 (87%) at 3 months, 349 (76%)
at 6 months, and 352 (76%) at 9 months.
Among study participants, 255 (55%) were women, 206
(45%) were men, the mean (SD) age was 47.5 (14.7) years, and
the mean (SD) body mass index (calculated as weight in kilo-
grams divided by height in meters squared) was 27.6 (5.1)
(Table 1). Sociodemographic characteristics, LBP history,
and primary and secondary outcome scores were similar be-
tween the 2 groups at baseline (Table 1). None of the partici-
pants reported any harms or adverse events.
Primary Outcome
From baseline to 3 months, the within-group mean (SD) change
in RMDQ score was 3.0 (4.5) points for the control group and
3.7 (4.5) points for the intervention group. At 3 months, the ad-
justed mean RMDQ score was −0.79 (95% CI, −1.51 to −0.06;
P = .03) points lower in the intervention group compared with
the control group (Table 2). This effect was sustained at
9 months (score, −0.88; 95% CI, −1.64 to −0.11 points) (Table 2,
Figure 2, and eTable 1 in Supplement 1) but was somewhat at-
tenuated in sensitivity analyses (score, −0.78; 95% CI, −1.54
to −0.03 points) (eTable 1 in Supplement 1).
The percentage of participants who reported a score
improvement of at least 4 points on the RMDQ from base-
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line to 3 months was 52% (n = 108 of 209 participants) in
the intervention group vs 39% (n = 74 of 190 participants)
in the control group, corresponding to an adjusted OR for
improvement in the intervention group of 1.76 (95% CI, 1.15-
2.70; P = .01) (Table 3 and Figure 2) compared with the con-
trol group. This result corresponded to a number needed
to treat of 7.3 (95% CI, 4.3-24.1). Analysis for the score
improvement of 2 points or more is presented in eTable 2 in
Supplement 1.
Secondary Outcomes
At 3 months, between-group differences in favor of the inter-
vention group were observed for average pain intensity level in
the preceding week (−0.62; 95% CI, −0.99 to −0.26; P = .001),
worst pain intensity level in the preceding week (−0.73; 95% CI,
−1.15 to −0.31; P = .001), Pain Self-Efficacy Questionnaire score
(2.52; 95% CI, 1.04-3.99; P = .001), Brief Illness Perception Ques-
tionnaire score (−4.57; 95% CI, −6.42 to −2.72; P < .001), and
Global Perceived Effect scale score (0.70; 95% CI, 0.39-1.01;




















Baseline 10.4 (4.4) NA
3-mo Follow-up 7.4 (5.4) 6.7 (4.7) −0.79 (−1.51 to −0.06)
9-mo Follow-up 6.9 (5.6) 6.0 (5.3) −0.88 (−1.64 to −0.11)
Secondary outcomes
Average pain intensity level
in preceding wk,
score range: 0-10
Baseline 4.9 (1.9) NA
3-mo Follow-up 3.9 (2.4) 3.3 (2.2) −0.62 (−0.99 to −0.26)
9-mo Follow-up 3.7 (2.4) 3.0 (2.3) −0.69 (−1.07 to −0.30)
Worst pain intensity level
in preceding wk,
score range: 0-10
Baseline 6.6 (1.9) NA
3-mo Follow-up 5.2 (2.7) 4.4 (2.5) −0.73 (−1.15 to −0.31)
9-mo Follow-up 5.0 (2.8) 4.0 (2.6) −1.00 (−1.45 to −0.56)
PSEQ score, range: 0-60
Baseline 44.1 (11.0) NA
3-mo Follow-up 46.6 (11.2) 49.2 (9.9) 2.52 (1.04 to 3.99)
9-mo Follow-up 46.9 (11.0) 50.2 (9.7) 3.25 (1.71 to 4.79)
FABQ score, range: 0-24
Baseline 10.3 (5.4) NA
3-mo Follow-up 9.1 (5.4) 8.6 (5.6) −0.43 (−1.34 to 0.48)
9-mo Follow-up 8.7 (5.6) 7.8 (5.5) −0.83 (−1.79 to 0.13)
BIPQ score, range: 0-80
Baseline 44.0 (10.9) NA
3-mo Follow-up 40.4 (13.5) 35.8 (14.2) −4.57 (−6.42 to −2.72)
9-mo Follow-up 38.0 (14.9) 34.1 (14.9) −3.88 (−5.81 to −1.95)
EQ-VAS score, range: 0-100
Baseline 66.2 (16.5) NA
3-mo Follow-up 70.6 (17.4) 70.9 (16.9) 0.36 (−2.42 to 3.14)
9-mo Follow-up 71.9 (17.9) 73.4 (16.1) 1.54 (−1.38 to 4.45)
EQ-5D weighted score,
range: −0.6 to 1.0
Baseline 0.70 (0.13) NA
3-mo Follow-up 0.74 (0.13) 0.76 (0.12) 0.02 (−0.01 to 0.04)
9-mo Follow-up 0.76 (0.14) 0.78 (0.13) 0.02 (0.00 to 0.05)
Global Perceived Effect
scale score, range: −5 to 5
Baseline NA NA
3-mo Follow-up 1.2 (1.9) 2.0 (1.9) 0.70 (0.39 to 1.01)
9-mo Follow-up 1.3 (2.2) 2.2 (2.0) 0.81 (0.49 to 1.15)
Abbreviations: BIPQ, Brief Illness
Perception Questionnaire;
EQ-5D, EuroQol-5 Dimension;
EQ-VAS, EuroQol visual analog scale;
FABQ, Fear-Avoidance Beliefs




a Marginal means were from a crude
linear mixed model, and SDs were
from raw data among persons with
information at the specific time
points.
b App-delivered self-management
support in addition to usual care.
c Adjusted for stratification variables
(country and clinician), educational
achievement (<10, 10-12, or
>12 years), duration of current pain
episode (<1, 1-4, 5-12, or >12 weeks),
average pain intensity level in the
past week at baseline (continuous,
range: 0-10), sex (male vs female),
and age (years).
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P < .001) (Table 2). Fear-avoidance beliefs, health-related qual-
ity of life (Table 2), and physical activity (eTable 3 in Supple-
ment 1) did not differ between groups at 3 months. The between-
group differences for the secondary outcomes were sustained
at 9 months (Table 2 and eTable 3 in Supplement 1), although
the differences were smaller than previously reported as clini-
cally relevant for populations with LBP. Exploratory outcomes
are reported in eTables 4 and 5 in Supplement 1.
Discussion
Among adults who sought care for LBP, those who were random-
ized to receive SELFBACK, an evidence-based and individually
tailored self-management support system delivered through
an AI-based app as an adjunct to usual care, showed reduced
pain-related disability at 3 months compared with those who
were randomized to receive usual care alone. However, this ef-
fect was less than the expected 2-point score improvement on
the RMDQ. The clinical significance of this finding is therefore
uncertain, although a larger percentage of participants in the in-
terventiongroupachievedaclinicallymeaningfulscoreimprove-
ment of 4 points or higher on the RMDQ at 3 months compared
with the control group (52% vs 39%). Between-group differences
for the secondary outcomes at 3 months favored the interven-
tion, but the effects were small. Overall, the results for the pri-
mary and secondary outcomes were sustained at 9 months.
To our knowledge, this randomized clinical trial was the
first to use an AI-based app to deliver evidence-based and in-
dividually tailored self-management support to adults with
LBP. Previously, AI was used in LBP classification but not for
prognosis or guiding treatment.43 The results of the current trial
complement evidence from previous systematic reviews of
randomized clinical trials that showed that nonpharmacologi-
cal active treatments, such as exercise or mindfulness-based
stress reduction, may ease LBP-related disability.44 Further-
more, a recent meta-analysis concluded that digital support
systems may be beneficial in LBP self-management.17
Although no general consensus on this issue has been
reached, a clinically relevant score improvement may range from
2 to 4 points on the RMDQ.27,29,30 The within-group RMDQ score
change at 3 months was 3.0 points for the control group and 3.7
points for the intervention group. Although the between-
group difference was smaller than the clinically relevant dif-
ference, the addition of the SELFBACK system to usual care may
potentially enable the achievement of a clinically meaningful
within-group change. This hypothesis is supported by the sub-
stantially larger percentage of participants achieving a score
improvement of 4 points or higher on the RMDQ in the inter-
vention group compared with the control group.
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Error bars represent 95% CIs.








No. of participants reporting
improvement/No. of
participants (% reporting) OR (95% CI)b
No. of participants reporting
improvement/No. of
participants (% reporting) OR (95% CI)b
Baseline 0/229 (NA) NA 0/232 (NA) NA NA
3-mo follow-up 74/190 (39) 1.11 (0.77- 1.61) 108/209 (52) 1.96 (1.25-3.07) 1.76 (1.15-2.70)
9-mo follow-up 82/182 (45) 1.50 (1.05-2.14) 95/170 (56) 2.45 (1.53-3.92) 1.63 (1.04-2.55)
Abbreviations: NA, not applicable; OR, odds ratio; RMDQ, Roland-Morris
Disability Questionnaire.
a App-delivered self-management support in addition to usual care.
b Adjusted for stratification variables (country and clinician), educational
achievement (<10, 10-12, or >12 years), duration of current pain episode
(<1, 1-4, 5-12, or >12 weeks), average pain intensity level in the past week at
baseline (continuous, range: 0-10), sex (male vs female), and age (years).
c Usual care was used as reference group.
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Strengths and Limitations
This trial has several strengths. First, it includes a patient-
centered intervention, well-balanced baseline characteris-
tics between groups, an intervention that was delivered ac-
cording to protocol, a smaller loss to follow-up than anticipated,
blinded analysis, and small but consistent between-group dif-
ferences for the primary outcome and several disparate sec-
ondary outcomes that were sustained at 9 months. Second,
the participants were recruited from diverse primary care set-
tings, and there were few restrictions on participant charac-
teristics and no upper limits on age, thereby enhancing the
generalizability of the findings. Further research is needed to
identify the active components of the intervention and the
potential moderators, such as digital health literacy. Process
evaluation,45 including interviews with participants and
clinicians, may provide valuable insights into how to refine the
SELFBACK app to increase its effectiveness.
The trial also has some limitations. First, the participants
werenotblinded.However,participantsintheinterventiongroup
did not receive additional attention from the researchers beyond
the app installation and initial instructions. Nevertheless, this
situation may have introduced a performance bias that overes-
timated the effect of the SELFBACK system. Second, health care
use was not monitored during the follow-up. A possible syner-
gistic effect between self-management support and usual care
cannot be excluded. Third, the step-detecting wristband worn
by participants in the intervention group may have introduced
an additional benefit that is independent of using the SELFBACK
app. Fourth, the per-protocol analyses could be biased if partici-
pants who engaged with the app during the follow-up period had
a different prognosis from those who had little app usage. Fur-
ther research is required to determine the cost-effectiveness and
long-term benefits (beyond 9 months) of the SELFBACK system.
Conclusions
Among adults with LBP who sought care in a primary care or
an outpatient spine clinic, those who received the AI-based
SELFBACK system as an adjunct to usual care had less LBP-
related disability at 3 months compared with those who re-
ceived usual care alone. This difference was sustained at
9 months. However, the improvement in pain-related disabil-
ity was small and of uncertain clinical significance. Process
evaluation may provide insights into refining the SELFBACK
app to increase its effectiveness.
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